What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Gene
Her primary areas of investigation include European Prospective Investigation into Cancer and Nutrition, Prospective cohort study, Internal medicine, Cohort study and Cohort.
Her studies deal with areas such as Environmental health, Gynecology and Risk factor as well as European Prospective Investigation into Cancer and Nutrition.
Her Prospective cohort study research is multidisciplinary, relying on both Relative risk, Colorectal cancer, Proportional hazards model and Hazard ratio.
Her Internal medicine research integrates issues from Gastroenterology, Endocrinology and Oncology.
Her work in Cohort study addresses issues such as Incidence, which are connected to fields such as Lung cancer.
Anne Tjønneland combines subjects such as Physical therapy and Obesity with her study of Body mass index.
Her most cited work include:
- Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults (2616 citations)
- Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants (2521 citations)
- General and abdominal adiposity and risk of death in Europe. (1562 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Internal medicine, Prospective cohort study, European Prospective Investigation into Cancer and Nutrition, Cohort study and Cohort.
Her study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Oncology.
The various areas that Anne Tjønneland examines in her Prospective cohort study study include Gerontology, Lower risk, Gynecology, Proportional hazards model and Colorectal cancer.
Her research investigates the connection between European Prospective Investigation into Cancer and Nutrition and topics such as Risk factor that intersect with issues in Relative risk.
Her Cohort study research is multidisciplinary, incorporating perspectives in Epidemiology, Incidence, Diabetes mellitus, Type 2 diabetes and Confounding.
Her biological study spans a wide range of topics, including Confidence interval and Environmental health.
She most often published in these fields:
- Internal medicine (57.92%)
- Prospective cohort study (39.85%)
- European Prospective Investigation into Cancer and Nutrition (35.87%)
What were the highlights of her more recent work (between 2018-2021)?
- Internal medicine (57.92%)
- Cohort (30.43%)
- Hazard ratio (17.66%)
In recent papers she was focusing on the following fields of study:
Anne Tjønneland mostly deals with Internal medicine, Cohort, Hazard ratio, Cohort study and Prospective cohort study.
Her Oncology research extends to Internal medicine, which is thematically connected.
Her work focuses on many connections between Cohort and other disciplines, such as Environmental health, that overlap with her field of interest in Air pollution.
Her Hazard ratio research includes themes of Proportional hazards model and Risk factor.
Her Prospective cohort study research incorporates elements of Breast cancer and Case-control study.
Her research on European Prospective Investigation into Cancer and Nutrition concerns the broader Body mass index.
Between 2018 and 2021, her most popular works were:
- Long-term residential exposure to PM2.5, PM10, black carbon, NO2, and ozone and mortality in a Danish cohort (76 citations)
- Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies (68 citations)
- Flavonoid intake is associated with lower mortality in the Danish Diet Cancer and Health Cohort (67 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Anne Tjønneland mainly focuses on Internal medicine, Cohort study, Prospective cohort study, Cohort and European Prospective Investigation into Cancer and Nutrition.
Her Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Endocrinology and Oncology.
Her Cohort study research includes elements of Incidence, Disease, Public health, Hazard ratio and Type 2 diabetes.
Her work carried out in the field of Prospective cohort study brings together such families of science as Framingham Risk Score, Pancreatic cancer, Case-control study, Breast cancer and Antibody.
The Cohort study combines topics in areas such as Waist–hip ratio and C-reactive protein.
In European Prospective Investigation into Cancer and Nutrition, Anne Tjønneland works on issues like Colorectal cancer, which are connected to Single-nucleotide polymorphism and Menopausal hormone therapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
